Toggle navigation
Home
Medical
FDA Approves 2-Month Dosing of Injectable HIV Drug Cabenuva
3-2-2022
Medical
https://www.medscape.com/cx/rssfeeds/2700.xml
104
The expanded approval doubles the time between doses from 4 to 8 weeks. Medscape Medical News
Share
Tweet
+1
Read The Rest
at : https://www.medscape.com/cx/rssfeeds/2700.xml
Related News
EU Panel Backs New Drug for Infant Immunization of RSV
FDA Approves Botox Competitor That Lasts Longer
UW Medicine researchers seek participants for Phase 3...
Mouth Cancer Action Month
DEXIS Days is here: Month-long series of free virtual...
Dental Infection Control Awareness Month: Commitment to...
Facing a monkeypox vaccines shortage, the U.S. is...
National Smile Month: 5 ways to get involved and engage...
How Often Should I Visit My Dentist? Does the Six-Month...
School visit for National Smile Month